Sesamolin
CAS No. 526-07-8
Sesamolin ( Sesamolin; AI3-20978; AI320978 )
产品货号. M18731 CAS No. 526-07-8
Sesamolin protects microglia against H2O2-induced cell injury, by inhibiting of p38 MAPK and caspase-3 activation and ROS production.
纯度: 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥583 | 有现货 |
|
10MG | ¥1037 | 有现货 |
|
25MG | ¥1774 | 有现货 |
|
50MG | ¥2641 | 有现货 |
|
100MG | ¥3937 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Sesamolin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Sesamolin protects microglia against H2O2-induced cell injury, by inhibiting of p38 MAPK and caspase-3 activation and ROS production.
-
产品描述Sesamolin and Sesamin has neuroprotective effect. Sesamolin protects microglia against H2O2-induced cell injury, by inhibiting of p38 MAPK and caspase-3 activation and ROS production. Sesamolin and Sesamin can significantly attenuate the excess generation of nitric oxide in lipopolysaccharide-stimulated rat primary microglia cells.
-
同义词Sesamolin; AI3-20978; AI320978
-
通路Others
-
靶点Other Targets
-
受体p38 MAPK;Caspase-3
-
研究领域——
-
适应症——
化学信息
-
CAS Number526-07-8
-
分子量370.35
-
分子式C20H18O7
-
纯度98%
-
溶解度——
-
SMILESC1C2C(COC2OC3=CC4=C(C=C3)OCO4)C(O1)C5=CC6=C(C=C5)OCO6
-
化学全称1,3-Benzodioxole, 5-(4-(1,3-benzodioxol-5-yloxy)tetrahydro-1H,3H-furo(3,4-c)furan-1-yl)-, (1S-(1alpha,3a alpha,4alpha,6a alpha))-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Sulfamethazine
Sulfamethazine is a sulfonamide antibacterial.
-
3-Methyl-2-oxobutano...
alpha-Ketoisovaleric acid is an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids.
-
3-Hydroxybakuchiol
3-Hydroxybakuchiol exerts cytotoxic and anti-proliferative effects on the TA3/Ha mouse mammary adenocarcinoma cell line and induces a decrease in the mitochondrial transmembrane potential, the activation of caspase-3, the opening of the mitochondrial permeability transport pore (MPTP) and nuclear DNA fragmentation.3-Hydroxybakuchiol has antitumor activity resulting from interactions with the ETC, a system that is already deficient in cancer cells.